Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Melanoma is the most lethal skin cancer. Most deaths from melanoma result from metastases. Semaphorins have been shown to inhibit neuronal and endothelial cell migration, but the effects of semaphorins on tumor metastasis have not been documented. We found that semaphorin 3F (SEMA3F) was markedly downregulated in highly metastatic human cell lines in vitro and in vivo, which suggested that it may be a metastasis inhibitor. Metastatic human melanoma cells were transfected with SEMA3F and implanted into mice; the resultant tumors did not metastasize. Rather, the primary tumors resembled benign nevi characterized by large areas of apoptosis, diminished vascularity, inhibition of hyperplasia in overlying epidermal cells, and encapsulated tumor borders delineated by thick layers of fibroblasts and collagen matrix. This phenotype is in stark contrast to highly invasive, vascular mock-transfected tumors. In vitro, tumor cells expressing SEMA3F had a diminished capacity to adhere and migrate on fibronectin. Consistent with semaphorin-mediated chemorepulsion of neurons, tumor cells expressing SEMA3F were chemorepulsive for vascular and lymphatic endothelial cells expressing neuropilin-2 (NRP2), a novel mechanism for a tumor angiogenesis inhibitor. The repulsive activity was abrogated by NRP2 RNA interference. Together these results indicate that SEMA3F is a potent metastasis inhibitor that targets both tumor and stromal cells and raise the possibility of SEMA3F having therapeutic potential.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591 · cited 1×
“For example, VEGF kinase inhibitors and soluble VEGFRs block VEGFR signaling needed for angiogenesis (43).”
Soker, S., Takashima, S., Miao, H. Q., Neufeld, G., & Klagsbrun, M. (1998) · Cell · doi:10.1016/s0092-8674(00)81402-6 · Cited by 2,463
Self-citationFidler, I. J. (1990) · PubMed · Cited by 1,278
Neuropilin Is a Semaphorin III Receptor
Kolodkin, A. L., Levengood, D. V., Rowe, E. G., Tai, Y.-T., Giger, R. J., & Ginty, D. D. (1997) · Cell · doi:10.1016/s0092-8674(00)80535-8 · Cited by 1,180
Neuropilin Is a Receptor for the Axonal Chemorepellent Semaphorin III
He, Z., & Tessier-Lavigne, M. (1997) · Cell · doi:10.1016/s0092-8674(00)80534-6 · Cited by 1,142
Plexin-Neuropilin-1 Complexes Form Functional Semaphorin-3A Receptors
Takahashi, T., Fournier, A., Nakamura, F., Wang, L.-H., Murakami, Y., Kalb, R. G., Fujisawa, H., & Strittmatter, S. M. (1999) · Cell · doi:10.1016/s0092-8674(00)80062-8 · Cited by 817
Lymphangiogenesis and cancer metastasis
Stacker, S. A., Achen, M. G., Jussila, L., Baldwin, M. E., & Alitalo, K. (2002) · Nature Reviews Cancer · doi:10.1038/nrc863 · Cited by 797
Chen, H., Chédotal, A., He, Z., Goodman, C. S., & Tessier-Lavigne, M. (1997) · Neuron · doi:10.1016/s0896-6273(00)80371-2 · Cited by 663
Kitsukawa, T., Shimizu, M., Sanbo, M., Hirata, T., Taniguchi, M., Bekku, Y., Yagi, T., & Fujisawa, H. (1997) · Neuron · doi:10.1016/s0896-6273(00)80392-x · Cited by 656
Abnormal lymphatic vessel development in neuropilin 2 mutant mice
Yuan, L., Moyon, D., Pardanaud, L., Bréant, C., Karkkainen, M. J., Alitalo, K., & Eichmann, A. (2002) · Development · doi:10.1242/dev.129.20.4797 · Cited by 632
Endostatin Induces Endothelial Cell Apoptosis
Dhanabal, M., Ramchandran, R., Waterman, M. J. F., Lu, H., Knebelmann, B., Segal, M., & Sukhatme, V. P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.11721 · Cited by 584
Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function
Serini, G., Valdembri, D., Zanivan, S., Morterra, G., Burkhardt, C., Caccavari, F., Zammataro, L., Primo, L., Tamagnone, L., Logan, M., et al. (2003) · Nature · doi:10.1038/nature01784 · Cited by 576
Integrins: roles in cancer development and as treatment targets
Jin, H., & Varner, J. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601576 · Cited by 574
Srivastava, A., Laidler, P., Davies, R. P., Horgan, K. J., & Hughes, L. E. (1988) · PubMed Central · Cited by 528
Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate
Hong, Y., Harvey, N., Noh, Y., Schacht, V., Hirakawa, S., Detmar, M., & Oliver, G. (2002) · Developmental Dynamics · doi:10.1002/dvdy.10163 · Cited by 528
Dadras, S. S., Paul, T., Bertoncini, J., Brown, L. F., Muzikansky, A., Jackson, D. G., Ellwanger, U., Garbe, C., Mihm, M. C., & Detmar, M. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64328-3 · Cited by 484
Interaction of endostatin with integrins implicated in angiogenesis
Rehn, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.031564998 · Cited by 460
Neuropilin-1 Mediates Collapsin-1/Semaphorin III Inhibition of Endothelial Cell Motility
Miao, H.-Q., Soker, S., Feiner, L., Alonso, J. L., Raper, J. A., & Klagsbrun, M. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.1.233 · Cited by 458
Self-citationSoker, S., Miao, H., Nomi, M., Takashima, S., & Klagsbrun, M. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10140 · Cited by 456
Self-citationPettaway, C. A., Pathak, S., Greene, G., Ramirez, E. I., Wilson, M. R., Killion, J. J., & Fidler, I. J. (1996) · PubMed · Cited by 408
Isaacs, J. T., Isaacs, W. B., Feitz, W. F. J., & Scheres, J. (1986) · The Prostate · doi:10.1002/pros.2990090306 · Cited by 407
Takashima, S., Kitakaze, M., Asakura, M., Asanuma, H., Sanada, S., Tashiro, F., Niwa, H., Miyazaki, J.-I., Hirota, S., Kitamura, Y., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022017899 · Cited by 372
Self-citationGiger, R. J., Urquhart, E. R., Gillespie, S. K. H., Levengood, D. V., Ginty, D. D., & Kolodkin, A. L. (1998) · Neuron · doi:10.1016/s0896-6273(00)80625-x · Cited by 349
Kim, Y. M., Jang, J.-W., Lee, O., Yeon, J.-H., Choi, E.-Y., Kim, K., Lee, S., & Kwon, Y. (2000) · PubMed · Cited by 347
Gagnon, M. L., Bielenberg, D. R., Gechtman, Z., Miao, H.-Q., Takashima, S., Soker, S., & Klagsbrun, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040337597 · Cited by 313
Self-citationJussila, L., Valtola, R., Partanen, T. A., Salvén, P., Heikkilä, P., Matikainen, M., Renkonen, R., Kaipainen, A., Detmar, M. J., Tschachler, E., et al. (1998) · PubMed · Cited by 312
Self-citationNeuropilin‐1 expression by tumor cells promotes tumor angiogenesis and progression
Miao, H., Lee, P., Lin, H., Soker, S., & Klagsbrun, M. (2000) · The FASEB Journal · doi:10.1096/fj.00-0250com · Cited by 312
Self-citationIntra-tumoural microvessel density in human solid tumours
Hasan, J., Byers, R., & Jayson, G. C. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600315 · Cited by 308
Semaphorin–Neuropilin Interactions Underlying Sympathetic Axon Responses to Class III Semaphorins
Chen, H., He, Z., Bagri, A., & Tessier-Lavigne, M. (1998) · Neuron · doi:10.1016/s0896-6273(00)80648-0 · Cited by 291
Differential expression of neuropilin-1 and neuropilin-2 in arteries and veins
Herzog, Y., Kalcheim, C., Kahane, N., Reshef, R., & Neufeld, G. (2001) · Mechanisms of Development · doi:10.1016/s0925-4773(01)00518-4 · Cited by 264
Plexin/neuropilin complexes mediate repulsion by the axonal guidance signal semaphorin 3A
Rohm, B., Ottemeyer, A., Lohrum, M., & Püschel, A. W. (2000) · Mechanisms of Development · doi:10.1016/s0925-4773(00)00269-0 · Cited by 249
Sekido, Y., Bader, S., Latif, F., Chen, J. Y., Duh, F. M., Wei, M. H., Albanesi, J. P., Lee, C. C., Lerman, M. I., & Minna, J. D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4120 · Cited by 232
A Human Melanoma Line Heterogeneous With Respect to Metastatic Capacity in Athymic Nude Mice 234
(1984) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/72.4.913 · Cited by 230
Semaphorin-3F Is an Inhibitor of Tumor Angiogenesis
Kessler, O., Shraga-Heled, N., Lange, T., Gutmann-Raviv, N., Sabo, E., Baruch, L., Machluf, M., & Neufeld, G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3090 · Cited by 227
The Role of Neuropilin in Vascular and Tumor Biology
Klagsbrun, M., Takashima, S., & Mamluk, R. (2002) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4615-0119-0_3 · Cited by 220
Self-citationLee, P., Goishi, K., Davidson, A. J., Mannix, R., Zon, L., & Klagsbrun, M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162366299 · Cited by 215
Self-citationTomizawa, Y., Sekido, Y., Kondo, M., Gao, B., Yokota, J., Roche, J., Drabkin, H., Lerman, M. I., Gazdar, A. F., & Minna, J. D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231490898 · Cited by 209
Soker, S., Gollamudi-Payne, S., Fidder, H., Charmahelli, H., & Klagsbrun, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31582 · Cited by 196
Self-citationSemaphorins III and IV repel hippocampal axons via two distinct receptors
Chédotal, A., Del Rio, J. A., Ruiz, M., He, Z., Borrell, V., de Castro, F., Ezan, F., Goodman, C. S., Tessier-Lavigne, M., Sotelo, C., et al. (1998) · Development · doi:10.1242/dev.125.21.4313 · Cited by 194
Distinct 3p21.3 deletions in lung cancer and identification of a new human semaphorin.
Roche, J., Boldog, F. L., Robinson, M., Robinson, L., Varella-Garcia, M., Swanton, M., Waggoner, B. T., Fishel, R. A., Franklin, W. A., Gemmill, R. M., et al. (1996) · PubMed · Cited by 191
Neuropilin-1 in Human Colon Cancer
Parikh, A. A., Fan, F., Liu, W. B., Ahmad, S. A., Stoeltzing, O., Reinmuth, N., Bielenberg, D., Bucana, C. D., Klagsbrun, M., & Ellis, L. M. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63772-8 · Cited by 169
Self-citationCollapsin Response Mediator Protein-1 and the Invasion and Metastasis of Cancer Cells
Shih, J.-Y., Yang, S., Hong, T.-M., Yuan, A., Chen, J. J. W., Yu, C., Chang, Y., Lee, Y., Peck, K., Wu, C. W., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.18.1392 · Cited by 161
Zanata, S. M., Hovatta, I., Rohm, B., & Püschel, A. W. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-02-00471.2002 · Cited by 161
Bates, D., Taylor, G. I., Minichiello, J., Farlie, P., Cichowitz, A., Watson, N., Klagsbrun, M., Mamluk, R., & Newgreen, D. F. (2003) · Developmental Biology · doi:10.1016/s0012-1606(02)00045-3 · Cited by 160
Self-citationDong, Z., Greene, G. L., Pettaway, C. A., Dinney, C. P., Eue, I., Lu, W., BUCANA, C. D., Balbay, M. D., Bielenberg, D. R., & Fidler, I. J. (1999) · PubMed · Cited by 146
Self-citationTse, C., Xiang, R. H., Bracht, T., & Naylor, S. L. (2002) · PubMed · Cited by 142
Molecular Regulation of UVB-Induced Cutaneous Angiogenesis
Bielenberg, D. R., Bucana, C. D., Sànchez, R., Donawho, C. K., Kripke, M. L., & Fidler, I. J. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00378.x · Cited by 142
Self-citationInvolvement of Fes/Fps tyrosine kinase in semaphorin3A signaling
三井, 教., Inatome, R., Takahashi, S., Goshima, Y., Yamamura, H., & Yanagi, S. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf328 · Cited by 136
Semaphorin 3F gene from human 3p21.3 suppresses tumor formation in nude mice.
Xiang, R., Davalos, A. R., Hensel, C. H., Zhou, X., Tse, C., & Naylor, S. L. (2002) · PubMed · Cited by 132
The Formation of Lymphatic Vessels and Its Importance in the Setting of Malignancy
Detmar, M. J., & Hirakawa, S. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021346 · Cited by 83
Harper, J., Gerstenfeld, L. C., & Klagsbrun, M. (2001) · Journal of Cellular Biochemistry · doi:10.1002/1097-4644(20010401)81:1<82::aid-jcb1025>3.0.co;2-p · Cited by 77
Self-citationCornil, I., Man, S., Fernandez, B., & Kerbel, R. S. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.12.938 · Cited by 69
McCarty, M. F., Bielenberg, D. R., Donawho, C. K., Bucana, C. D., & Fidler, I. J. (2002) · Clinical & Experimental Metastasis · doi:10.1023/a:1020923326441 · Cited by 64
Self-citationCritical determinants of melanoma metastasis.
Fidler, I. J. (1996) · PubMed · Cited by 46
Kusy, S. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00197-0 · Cited by 18
Research works printed but not linked: 17
- 10.1006/geno.1999.5790 · doi:10.1006/geno.1999.5790
- Roche, 1996, Oncogene., 12, 1289
- Tse, 2002, Cancer Res., 62, 542
- Xiang, 2002, Cancer Res., 62, 2637
- Fidler, 1996, J. Investig. Dermatol. Symp. Proc., 1, 203
- 10.1006/geno.1996.0074 · doi:10.1006/geno.1996.0074
- 10.1136/jcp.54.3.196 · doi:10.1136/jcp.54.3.196
- Fidler, 1990, Cancer Res., 50, 6130
- Nasarre, 2003, Neoplasia., 5, 83, 10.1016/S1476-5586(03)80020-9 · doi:10.1016/s1476-5586(03)80020-9
- 10.1097/00008390-200308000-00007 · DOI
- Srivastava, 1988, Am. J. Pathol., 133, 419
- Kim, 2000, Cancer Res., 60, 5410
- Kozlowski, 1984, J. Natl. Cancer Inst., 72, 913
- 10.1016/S0022-5347(01)66923-4 · doi:10.1016/s0022-5347(01)66923-4
- Pettaway, 1996, Clin. Cancer Res., 2, 1627
- Jussila, 1998, Cancer Res., 58, 1599
- Dong, 1999, Cancer Res., 59, 872
Cited by
Normalization of the Vasculature for Treatment of Cancer and Other Diseases
Goel, S., Duda, D. G., Xu, L., Munn, L. L., Boucher, Y., Fukumura, D., & Jain, R. K. (2011) · Physiological Reviews · doi:10.1152/physrev.00038.2010 · Cited by 1,605
“In the peripheral nervous system, VEGF activity is modulated by the semaphorins, which act via the neuropilin receptors as negative regulators of angiogenesis (26, 169, 170).”
Jain, R. K., di Tomaso, E., Duda, D. G., Loeffler, J. S., Sorensen, A. G., & Batchelor, T. T. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2175 · Cited by 1,405
The senescence-associated secretory phenotype and its regulation
Lopes-Paciencia, S., Saint-Germain, E., Rowell, M.-C., Ruiz, A. F., Kalegari, P., & Ferbeyre, G. (2019) · Cytokine · doi:10.1016/j.cyto.2019.01.013 · Cited by 601
Tumour vascularization: sprouting angiogenesis and beyond
Hillen, F., & Griffioen, A. W. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9094-7 · Cited by 583
Semaphorins command cells to move
Kruger, R. P., Aurandt, J., & Guan, K.-L. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1740 · Cited by 491
Metadata
- Authors
- Bielenberg, D. R., Hida, Y., Shimizu, A., Kaipainen, A., Kreuter, M., Kim, C. C., & Klagsbrun, M.
- Venue
- Journal of Clinical Investigation
- Published
- 2004-11-01
- Volume
- 114
- Issue
- 9
- Pages
- 1260-1271
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2096643761
- Cited by
- 286
- References
- 55
- FWCI
- 6.45
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.